NewAmsterdam Pharma (NAMS) Share-based Compensation (2023 - 2026)
NewAmsterdam Pharma (NAMS) reported Share-based Compensation of $18.38 million for Q2 2026, up 21.1% from $15.18 million a year earlier and up 2.1% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Share-based Compensation (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, NewAmsterdam Pharma's Share-based Compensation came in at $65.42 million, up 36.8% year-over-year; for FY2025, it came in at $59.43 million, up 76.8% from FY2024.
- Share-based Compensation has increased for four consecutive years, with a four-year compound annual growth rate of 162.9% (FY2021 to FY2025).
- By year, Share-based Compensation came in at $33.62 million in FY2024 (+36.8%), $24.57 million in FY2023 (+496.8%), $4.12 million in FY2022 (+230.9%) and $1.24 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation in data going back to Q1 2023.
- Year over year, Share-based Compensation has now increased in each of the last ten quarters, with growth averaging 57.0% over the last eight quarters.
- Over the past five years, the year-over-year growth in Share-based Compensation ranged from 4.0% (Q1 2024) to 92.1% (Q1 2025).
- Per Business Quant data, the three quarters before Q2 2026 came in at $18 million (Q1 2026), $14.02 million (Q4 2025) and $15.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | NewAmsterdam Pharma | 2.77 Bn | 2.77 Bn | - | 18.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.38 Mn |
| Mar 31, 2026 | 18.00 Mn |
| Dec 31, 2025 | 14.02 Mn |
| Sep 30, 2025 | 15.01 Mn |
| Jun 30, 2025 | 15.18 Mn |
| Mar 31, 2025 | 15.21 Mn |
| Dec 31, 2024 | 9.42 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 8.29 Mn |
| Mar 31, 2024 | 7.92 Mn |
| Dec 31, 2023 | 6.01 Mn |
| Sep 30, 2023 | 5.39 Mn |
| Jun 30, 2023 | 5.56 Mn |
| Mar 31, 2023 | 7.62 Mn |
API Access
NewAmsterdam Pharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();